Male or female, aged 18 years and older
Aged 18 years and older on the day of signing informed consent
Aged 18 years or older.
Is male or female, aged 18 years or older at the time of consent; preferably non-Asian.
Male or female aged 18 or older
Aged 18 years or older
Men and women, aged 18 years or older (except in South Korea, aged 19 or older).
Male and non-pregnant females who are aged 18 years or older at the time of provision of informed consent.
Adult men and women aged 18 and older
Aged 18 years or older
Patients aged 18 years or older
Aged 18 years or older at the time of consent
Adult aged 18 years or older
Males or females aged 18 years or older
Male or female participants aged 18 years or older.
Aged 18 years or older, with lymphoid malignancies of B-cell origin including:
Male aged 18 or older with metastatic adenocarcinoma of the prostate
Male or female aged 18 years and older.
Male aged 18 years and older.
Male or female, aged 18 years or older
Male or female, aged 18 years or older
Patients aged 20 years and older at the time of tentative registration (with no upper age limit)
Men and women, aged 18 or older (except in South Korea, aged 19 or older).
Females, aged 18 years or older
Patients aged 18 years or older, inclusive
Men and women, aged 18 years or older
Males or females aged 18 or older
Aged 18 years and older
Aged 18 years or older
Male or female aged 18 years or older.
Aged 18 years or older
Male or female patient aged 18 years or older.
Male or female participants aged 18 years or older.
Males or females aged 18 years or older
A male or female, aged 18 years or older at the time of study entry.
Male or female subject aged 18 years or older.
Is a male or female participant aged 18 years or older.
Female participants aged 18 years or older who are postmenopausal.
